학술논문
Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy
Document Type
Article
Author
Grande, E.; Alonso-Gordoa, T.; Reig, O.; Esteban, E.; Castellano, D.; Garcia-del-Muro, X.; Mendez, M.J.; García-Donas, J.; González Rodríguez, M.; Arranz-Arija, J.A.; Lopez-Criado, P.; Molina-Cerrillo, J.; Mellado, B.; Alvarez-Fernandez, C.; De Velasco, G.; Cuéllar-Rivas, M.A.; Rodríguez-Alonso, R.M.; Rodríguez-Moreno, J.F.; Suarez-Rodriguez, C.
Source
In ESMO Open April 2022 7(2)
Subject
Language
ISSN
2059-7029